Feil Family Brain & Mind Research Institute

You are here

News

Early Sensory Stimulation is Critical for the Development of Sensory Networks

Sensory stimulation during a critical period soon after birth is essential for establishing networks in the brain that “map” sensations and enable the development of normal behaviors, according to a new study by Weill Cornell Medicine investigators.

The paper, published in print July 11 and online June 19 in Neuron, is the first to observe the early functional development of specialized nerve cells, called...

Read More

Dr. Li Gan to Lead Appel Alzheimer’s Research Institute

Dr. Li Gan, a neuroscientist internationally acclaimed for her research into neurodegenerative diseases, has been appointed director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine.

For more information:

...

Read More

Leon Levy Fellowship Applications due July 1, 2018

Leon Levy Request for Applications  
Due: July 1st, 2018  

For application and questions - contact Veronica Bohorquez, veb2012@med.cornell.edu


Costantino Iadecola, M.D.
Anne Parrish Titzell Professor of Neurology
Director and Chair, Feil Family Brain and Mind Research Institute

May 30...

Read More

Winner of the 2017 BMRI Paper of the Year Award

Dear Colleagues:

  I am happy to report that the winner of the BMRI Paper of the Year Award is “Resting-state connectivity biomarkers define neurophysiological subtypes of depression.” Nat Med. (2017) 23(1):28-38, by Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

  We...

Read More

A High-Salt Diet Produces Dementia in Mice

A high-salt diet reduces resting blood flow to the brain and causes dementia in mice, according to a new study by scientists from Weill Cornell Medicine.

The study, published Jan. 15 in Nature Neuroscience, is the first to unveil a gut-brain connection linking high dietary salt intake to neurovascular and cognitive impairment. The findings illuminate a potential future target for countering harmful effects to the brain...

Read More

Weill Cornell and NewYork-Presbyterian Physician Makes Recommendation for Treatment of Congenital Heart Defect Related to Stroke

Young people with a history of strokes caused by blood clots should be evaluated for a congenital condition characterized by a hole in the heart. If present, surgical closure should be considered to prevent future stroke, according to an editorial by a Weill Cornell Medicine and NewYork-Presbyterian neurologist.

Patent foramen ovale (PFO) is a hole in the wall between the right and left sides of the heart. It occurs...

Read More

Symposium Fosters Entrepreneurial Spirit at Weill Cornell Medicine

Dr. Timothy McGraw calls himself “the accidental entrepreneur.”

Some seven years ago, the Weill Cornell Medicine biochemist began a side project investigating whether renegade hormones in the blood could be the culprit for the kind of insulin resistance that sparks type 2 diabetes. Dr. McGraw in 2014 pitched his hypothesis to Larry Schlossman, managing...

Read More

Dr. Nicholas Schiff is awarded Daedalus Fund for Innovation

Dynamic Multi-Lead Deep Brain Stimulation of the Central Thalamus to Treat Chronic Cognitive Deficits in Severe-to-Moderate Traumatic Brain Injured Patients

Read More

ARCADIA Trial Will Test Link Between Stroke and a Common Heart Condition

NEW YORK (August 15, 2017) - A new clinical trial led by investigators at NewYork-Presbyterian, Columbia University Medical Center (CUMC) and Weill Cornell Medicine aims to identify and treat what may be a common underlying cause of recurrent strokes. ARCADIA, a multicenter phase III trial, will study the role of abnormalities in the structure and function of the heart’s left atrium, or atrial cardiopathy, in stroke patients, and...

Read More

Missing Link Identified Between Immune Cells and Alzheimer’s

By studying the effects of immune cells that surround blood vessels in the brain, Weill Cornell Medicine researchers have discovered a new pathway involving these cells that may contribute to the cause of Alzheimer’s disease.

One of the hallmarks of Alzheimer’s disease is the accumulation of plaque deposits, or abnormal protein fragments, from a peptide called amyloid-beta. Amyloid-beta destroys neurons and damages brain blood vessels with the help of highly reactive molecules, called...

Read More

Weill Cornell Medicine Feil Family Brain & Mind Research Institute 407 E 61st St New York, NY 10065 Phone: (646) 962-8277 Fax: (646) 962-0535